Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Savoldo

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Blood|February 1, 2011
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsConcetta Quintarelli, Gianpietro Dotti, Sayyeda T Hasan, et al.
Blood|October 24, 2002
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infectionBarbara Savoldo, M Helen Huls, Zhensheng Liu, et al.
Blood|February 24, 2021
Utility of a safety switch to abrogate CD19.CAR T-cell-associated neurotoxicityMatthew C Foster, Barbara Savoldo, Winnie Lau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 15, 2011
Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphomaUlrike Gerdemann, Usha Katari, Anne S Christin, et al.
Stem Cells (Dayton, Ohio)|June 23, 2009
Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cellsDavid Steiner, Juri Gelovani, Barbara Savoldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2019
NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced <i>In Vivo</i> Persistence and Antitumor Activity against NeuroblastomaXin Xu, Wei Huang, Andras Heczey, et al.
Blood Advances|October 19, 2021
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphomaTimothy J Voorhees, Beibo Zhao, Jorge Oldan, et al.
Ebiomedicine|August 31, 2019
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheresDean Nehama, Natalia Di Ianni, Silvia Musio, et al.
The Journal of Clinical Investigation|May 5, 2011
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patientsBarbara Savoldo, Carlos Almeida Ramos, Enli Liu, et al.
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Blood|February 1, 2011
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsConcetta Quintarelli, Gianpietro Dotti, Sayyeda T Hasan, et al.
Blood|October 24, 2002
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infectionBarbara Savoldo, M Helen Huls, Zhensheng Liu, et al.
Blood|February 24, 2021
Utility of a safety switch to abrogate CD19.CAR T-cell-associated neurotoxicityMatthew C Foster, Barbara Savoldo, Winnie Lau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 15, 2011
Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphomaUlrike Gerdemann, Usha Katari, Anne S Christin, et al.
Stem Cells (Dayton, Ohio)|June 23, 2009
Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cellsDavid Steiner, Juri Gelovani, Barbara Savoldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2019
NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced <i>In Vivo</i> Persistence and Antitumor Activity against NeuroblastomaXin Xu, Wei Huang, Andras Heczey, et al.
Blood Advances|October 19, 2021
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphomaTimothy J Voorhees, Beibo Zhao, Jorge Oldan, et al.
Ebiomedicine|August 31, 2019
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheresDean Nehama, Natalia Di Ianni, Silvia Musio, et al.
The Journal of Clinical Investigation|May 5, 2011
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patientsBarbara Savoldo, Carlos Almeida Ramos, Enli Liu, et al.
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Pageof 16